vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and NATURAL HEALTH TRENDS CORP (NHTC). Click either name above to swap in a different company.

CuriosityStream Inc. is the larger business by last-quarter revenue ($19.2M vs $9.7M, roughly 2.0× NATURAL HEALTH TRENDS CORP). NATURAL HEALTH TRENDS CORP runs the higher net margin — -6.0% vs -19.7%, a 13.7% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -10.1%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-964.0K). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -5.6%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Sword Health is a digital health company that develops physical therapy programs for musculoskeletal (MSK) conditions, pelvic health, and injury prevention. The company was founded in 2015 in Portugal by Virgílio Bento and Márcio Colunas. Its services include digital physical therapy with artificial intelligence (AI) integrated into the care model. As of 2024, Sword Health operates internationally, with offices in the United States, Ireland, and Portugal. The company has been valued at $3 bil...

CURI vs NHTC — Head-to-Head

Bigger by revenue
CURI
CURI
2.0× larger
CURI
$19.2M
$9.7M
NHTC
Growing faster (revenue YoY)
CURI
CURI
+45.9% gap
CURI
35.8%
-10.1%
NHTC
Higher net margin
NHTC
NHTC
13.7% more per $
NHTC
-6.0%
-19.7%
CURI
More free cash flow
CURI
CURI
$4.9M more FCF
CURI
$3.9M
$-964.0K
NHTC
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
-5.6%
NHTC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
NHTC
NHTC
Revenue
$19.2M
$9.7M
Net Profit
$-3.8M
$-588.0K
Gross Margin
72.9%
Operating Margin
-17.6%
-6.5%
Net Margin
-19.7%
-6.0%
Revenue YoY
35.8%
-10.1%
Net Profit YoY
-34.6%
-434.1%
EPS (diluted)
$-0.07
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
NHTC
NHTC
Q4 25
$19.2M
$9.7M
Q3 25
$18.4M
$9.5M
Q2 25
$19.0M
$9.8M
Q1 25
$15.1M
$10.7M
Q4 24
$14.1M
$10.8M
Q3 24
$12.6M
$10.7M
Q2 24
$12.4M
$10.5M
Q1 24
$12.0M
$11.0M
Net Profit
CURI
CURI
NHTC
NHTC
Q4 25
$-3.8M
$-588.0K
Q3 25
$-3.7M
$-431.0K
Q2 25
$784.0K
$15.0K
Q1 25
$319.0K
$122.0K
Q4 24
$-2.8M
$176.0K
Q3 24
$-3.1M
$35.0K
Q2 24
$-2.0M
$173.0K
Q1 24
$-5.0M
$188.0K
Gross Margin
CURI
CURI
NHTC
NHTC
Q4 25
72.9%
Q3 25
73.7%
Q2 25
73.9%
Q1 25
73.6%
Q4 24
74.2%
Q3 24
74.1%
Q2 24
74.2%
Q1 24
73.4%
Operating Margin
CURI
CURI
NHTC
NHTC
Q4 25
-17.6%
-6.5%
Q3 25
-24.5%
-5.2%
Q2 25
2.5%
-3.4%
Q1 25
0.5%
-3.2%
Q4 24
-27.4%
-3.9%
Q3 24
-25.8%
-2.6%
Q2 24
-20.6%
-2.3%
Q1 24
-30.4%
-3.3%
Net Margin
CURI
CURI
NHTC
NHTC
Q4 25
-19.7%
-6.0%
Q3 25
-20.4%
-4.5%
Q2 25
4.1%
0.2%
Q1 25
2.1%
1.1%
Q4 24
-19.9%
1.6%
Q3 24
-24.3%
0.3%
Q2 24
-16.4%
1.7%
Q1 24
-42.0%
1.7%
EPS (diluted)
CURI
CURI
NHTC
NHTC
Q4 25
$-0.07
$-0.05
Q3 25
$-0.06
$-0.04
Q2 25
$0.01
$0.00
Q1 25
$0.01
$0.01
Q4 24
$-0.05
$0.01
Q3 24
$-0.06
$0.00
Q2 24
$-0.04
$0.02
Q1 24
$-0.09
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
NHTC
NHTC
Cash + ST InvestmentsLiquidity on hand
$27.3M
$28.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$23.4M
Total Assets
$75.7M
$38.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
NHTC
NHTC
Q4 25
$27.3M
$28.9M
Q3 25
$27.8M
$32.0M
Q2 25
$28.1M
$34.2M
Q1 25
$33.4M
$41.9M
Q4 24
$32.1M
$43.9M
Q3 24
$33.2M
$46.3M
Q2 24
$39.5M
$48.7M
Q1 24
$38.8M
$54.4M
Stockholders' Equity
CURI
CURI
NHTC
NHTC
Q4 25
$41.5M
$23.4M
Q3 25
$47.2M
$26.1M
Q2 25
$49.8M
$28.9M
Q1 25
$58.1M
$30.9M
Q4 24
$57.8M
$32.9M
Q3 24
$62.2M
$35.3M
Q2 24
$64.8M
$37.3M
Q1 24
$67.0M
$39.4M
Total Assets
CURI
CURI
NHTC
NHTC
Q4 25
$75.7M
$38.4M
Q3 25
$74.7M
$42.3M
Q2 25
$78.7M
$45.2M
Q1 25
$85.3M
$53.2M
Q4 24
$86.2M
$55.4M
Q3 24
$87.6M
$58.3M
Q2 24
$90.9M
$61.5M
Q1 24
$94.6M
$67.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
NHTC
NHTC
Operating Cash FlowLast quarter
$4.0M
$-959.0K
Free Cash FlowOCF − Capex
$3.9M
$-964.0K
FCF MarginFCF / Revenue
20.5%
-9.9%
Capex IntensityCapex / Revenue
0.1%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
NHTC
NHTC
Q4 25
$4.0M
$-959.0K
Q3 25
$4.4M
$113.0K
Q2 25
$2.8M
$-5.6M
Q1 25
$1.9M
$484.0K
Q4 24
$3.0M
$88.0K
Q3 24
$2.3M
$-436.0K
Q2 24
$2.2M
$-3.6M
Q1 24
$666.0K
$549.0K
Free Cash Flow
CURI
CURI
NHTC
NHTC
Q4 25
$3.9M
$-964.0K
Q3 25
$70.0K
Q2 25
$-5.6M
Q1 25
$1.8M
$468.0K
Q4 24
$68.0K
Q3 24
$-443.0K
Q2 24
$-3.6M
Q1 24
$538.0K
FCF Margin
CURI
CURI
NHTC
NHTC
Q4 25
20.5%
-9.9%
Q3 25
0.7%
Q2 25
-57.5%
Q1 25
12.2%
4.4%
Q4 24
0.6%
Q3 24
-4.1%
Q2 24
-34.2%
Q1 24
4.9%
Capex Intensity
CURI
CURI
NHTC
NHTC
Q4 25
0.1%
0.1%
Q3 25
0.0%
0.5%
Q2 25
0.0%
0.0%
Q1 25
0.5%
0.1%
Q4 24
0.0%
0.2%
Q3 24
0.0%
0.1%
Q2 24
0.0%
0.2%
Q1 24
0.0%
0.1%
Cash Conversion
CURI
CURI
NHTC
NHTC
Q4 25
Q3 25
Q2 25
3.56×
-375.67×
Q1 25
6.03×
3.97×
Q4 24
0.50×
Q3 24
-12.46×
Q2 24
-20.62×
Q1 24
2.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons